These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
412 related articles for article (PubMed ID: 35716036)
1. Sprouty1 exerts a preventive effect on the initiation of psoriasis by inhibiting innate immune antimicrobial peptide cathelicidin and immunocytes. Zhou Y; Wang P; Chen XY; Yan BX; Landeck L; Wang ZY; Xu F; Zheng M; Man XY Cell Prolif; 2022 Oct; 55(10):e13290. PubMed ID: 35716036 [TBL] [Abstract][Full Text] [Related]
2. Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin inflammation. Wang Z; Zhou H; Zheng H; Zhou X; Shen G; Teng X; Liu X; Zhang J; Wei X; Hu Z; Zeng F; Hu Y; Hu J; Wang X; Chen S; Cheng J; Zhang C; Gui Y; Zou S; Hao Y; Zhao Q; Wu W; Zhou Y; Cui K; Huang N; Wei Y; Li W; Li J Autophagy; 2021 Feb; 17(2):529-552. PubMed ID: 32019420 [TBL] [Abstract][Full Text] [Related]
3. Visfatin enhances the production of cathelicidin antimicrobial peptide, human β-defensin-2, human β-defensin-3, and S100A7 in human keratinocytes and their orthologs in murine imiquimod-induced psoriatic skin. Hau CS; Kanda N; Noda S; Tatsuta A; Kamata M; Shibata S; Asano Y; Sato S; Watanabe S; Tada Y Am J Pathol; 2013 May; 182(5):1705-17. PubMed ID: 23499548 [TBL] [Abstract][Full Text] [Related]
5. Ginsenoside Compound K Reduces Psoriasis-related Inflammation by Activation of the Glucocorticoid Receptor in Keratinocytes. Wang W; Xu X; Yang M; Jiang M; Wang D; Tang C; Wei W; Chen J Curr Mol Pharmacol; 2024 Feb; 17():e18761429254358. PubMed ID: 38389423 [TBL] [Abstract][Full Text] [Related]
6. IL-23/IL-17 immune axis mediates the imiquimod-induced psoriatic inflammation by activating ACT1/TRAF6/TAK1/NF-κB pathway in macrophages and keratinocytes. Chen WC; Wen CH; Wang M; Xiao ZD; Zhang ZZ; Wu CL; Wu R Kaohsiung J Med Sci; 2023 Aug; 39(8):789-800. PubMed ID: 37098777 [TBL] [Abstract][Full Text] [Related]
7. Chrysin alleviates imiquimod-induced psoriasis-like skin inflammation and reduces the release of CCL20 and antimicrobial peptides. Li HJ; Wu NL; Pu CM; Hsiao CY; Chang DC; Hung CF Sci Rep; 2020 Feb; 10(1):2932. PubMed ID: 32076123 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of JAK1/STAT3 pathway by 2-methoxyestradiol ameliorates psoriatic features in vitro and in an imiquimod-induced psoriasis-like mouse model. Tang J; Liu C; Liu S; Zhou X; Lu J; Li M; Zhu L Eur J Pharmacol; 2022 Oct; 933():175276. PubMed ID: 36130639 [TBL] [Abstract][Full Text] [Related]
9. IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes. Peric M; Koglin S; Kim SM; Morizane S; Besch R; Prinz JC; Ruzicka T; Gallo RL; Schauber J J Immunol; 2008 Dec; 181(12):8504-12. PubMed ID: 19050268 [TBL] [Abstract][Full Text] [Related]
10. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells. Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075 [TBL] [Abstract][Full Text] [Related]
11. Bruton's tyrosine kinase inhibitor suppresses imiquimod-induced psoriasis-like inflammation in mice through regulation of IL-23/IL-17A in innate immune cells. Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Alasmari AF; Alanazi WA; Alasmari F; Ibrahim KE; Al-Harbi MM; Bakheet SA; Attia SM Int Immunopharmacol; 2020 Mar; 80():106215. PubMed ID: 31982823 [TBL] [Abstract][Full Text] [Related]
12. Allicin ameliorates imiquimod-induced psoriasis-like skin inflammation via disturbing the interaction of keratinocytes with IL-17A. Zhang L; Ma X; Shi R; Zhang L; Zhao R; Duan R; Qin Y; Gao S; Li X; Duan J; Li J Br J Pharmacol; 2023 Mar; 180(5):628-646. PubMed ID: 36355777 [TBL] [Abstract][Full Text] [Related]
13. Alarmin function of cathelicidin antimicrobial peptide LL37 through IL-36γ induction in human epidermal keratinocytes. Li N; Yamasaki K; Saito R; Fukushi-Takahashi S; Shimada-Omori R; Asano M; Aiba S J Immunol; 2014 Nov; 193(10):5140-8. PubMed ID: 25305315 [TBL] [Abstract][Full Text] [Related]
14. NETs contribute to psoriasiform skin inflammation: A novel therapeutic approach targeting IL-36 cytokines by a small molecule tetrahydroxystilbene glucoside. Zhan ZY; Jiang M; Zhang ZH; An YM; Wang XY; Wu YL; Nan JX; Lian LH Phytomedicine; 2024 Aug; 131():155783. PubMed ID: 38838402 [TBL] [Abstract][Full Text] [Related]
15. Serine deficiency exacerbates psoriatic skin inflammation by regulating S-adenosyl methionine-dependent DNA methylation and NF-κB signalling activation in keratinocytes. Meng Q; Liu Y; Yao L; Ma Z; Guo L; Hu T; Luo Y; Chen J; Dang E; Li Z J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):145-156. PubMed ID: 37669859 [TBL] [Abstract][Full Text] [Related]
16. The STING antagonist H-151 ameliorates psoriasis via suppression of STING/NF-κB-mediated inflammation. Pan Y; You Y; Sun L; Sui Q; Liu L; Yuan H; Chen C; Liu J; Wen X; Dai L; Sun H Br J Pharmacol; 2021 Dec; 178(24):4907-4922. PubMed ID: 34460100 [TBL] [Abstract][Full Text] [Related]
17. Ethanol extract of Herpetospermum caudigerum Wall ameliorates psoriasis-like skin inflammation and promotes degradation of keratinocyte-derived ICAM-1 and CXCL9. Zhong Y; Zhang BW; Li JT; Zeng X; Pei JX; Zhang YM; Yang YX; Li FL; Deng Y; Zhao Q J Integr Med; 2023 Nov; 21(6):584-592. PubMed ID: 37989697 [TBL] [Abstract][Full Text] [Related]
18. Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1-high T cells. Kim JH; Choi YJ; Lee BH; Song MY; Ban CY; Kim J; Park J; Kim SE; Kim TG; Park SH; Kim HP; Sung YC; Kim SC; Shin EC J Allergy Clin Immunol; 2016 May; 137(5):1466-1476.e3. PubMed ID: 26824999 [TBL] [Abstract][Full Text] [Related]
19. Anthralin modulates the expression pattern of cytokeratins and antimicrobial peptides by psoriatic keratinocytes. Holstein J; Fehrenbacher B; Brück J; Müller-Hermelink E; Schäfer I; Carevic M; Schittek B; Schaller M; Ghoreschi K; Eberle FC J Dermatol Sci; 2017 Sep; 87(3):236-245. PubMed ID: 28673488 [TBL] [Abstract][Full Text] [Related]
20. Zhang H; Ren C; Liu Q; Wang Q; Wang D Allergol Immunopathol (Madr); 2023; 51(3):124-134. PubMed ID: 37169570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]